Body composition phenotyping of obesity in children aged 6-18 years: multi-strategy clustering and interpretable

Yuhang Wang1,2, Shuang Shi2,3, Jin Cai2

  • 1Yiwu Maternity and Children Hospital, Yiwu, Zhejiang, China.

Insights

This study identifies four distinct body composition phenotypes in obese children using non-invasive measures. These phenotypes, including low-fat/high-muscle and high-fat/low-muscle, offer a more nuanced understanding beyond BMI.

Area of Science:

  • Pediatric Endocrinology
  • Obesity Research
  • Body Composition Analysis

Background:

  • Childhood obesity heterogeneity is not fully captured by Body Mass Index (BMI).
  • Non-invasive measures are needed for operational phenotyping of pediatric obesity.
  • Existing metrics lack the granularity to describe diverse body compositions in obese youth.

Purpose of the Study:

  • To identify body composition-based phenotypes in obese children aged 6-18 years.
  • To utilize complementary clustering approaches for phenotype identification.
  • To characterize the discriminative structure of these phenotypes using interpretable machine learning.

Main Methods:

  • Cross-sectional study of 78 obese children (6-18 years).
  • Analysis of 13 Bioelectrical Impedance Analysis (BIA)-derived indices using PCA-K-means, HCPC, and UMAP-DBSCAN.
  • Evaluation of cluster quality, stability, and agreement using silhouette scores, Jaccard bootstrap, and Adjusted Rand Index (ARI).
  • Assessment of separability with a random forest classifier and SHAP for interpretability.

Main Results:

  • Four consistent phenotypes were identified: low-fat/high-muscle, balanced, high-fat/low-muscle, and mixed high-fat/high-muscle.
  • The classification model achieved 85.9% accuracy, with macro AUC of 0.953 and micro AUC of 0.965.
  • SHAP analysis highlighted fat mass and BMI as key discriminators, with opposing contributions from lean and skeletal muscle mass.

Conclusions:

  • This study presents an exploratory, single-center framework for phenotyping childhood obesity based on body composition.
  • The identified phenotypes provide a more detailed characterization than BMI alone.
  • External validation with outcome-linked markers and imaging is required before clinical application.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...